132 related articles for article (PubMed ID: 31663692)
21. Investigation of
Yang J; Liu J; Chen Y; Tang W; Bo K; Sun Y; Chen J
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31235485
[TBL] [Abstract][Full Text] [Related]
22. Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
Wang Z; Liao J; Wu S; Li C; Fan J; Peng Z
Cancer Gene Ther; 2016 Jun; 23(6):157-61. PubMed ID: 27173880
[TBL] [Abstract][Full Text] [Related]
23. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
[TBL] [Abstract][Full Text] [Related]
24. CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.
Chou YE; Hsieh MJ; Chiou HL; Lee HL; Yang SF; Chen TY
Biomed Res Int; 2014; 2014():231474. PubMed ID: 24971320
[TBL] [Abstract][Full Text] [Related]
25. miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients.
Yu G; Xiao Q; Ma XP; Chen X; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Sun J; Conran C; Zheng SL; Xu J; Yu L; Jiang DK
Tumour Biol; 2016 Jul; 37(7):8961-72. PubMed ID: 26753964
[TBL] [Abstract][Full Text] [Related]
26. Mannose-binding lectin 2 rs11003123 polymorphism is associated with the development of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis in the Chinese population.
Wang PS; Kuai J; Li H; Wang CG; Shi BJ; Zhong L
Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):282-8. PubMed ID: 27298104
[TBL] [Abstract][Full Text] [Related]
27. Association of intercellular adhesion molecule-1 single nucleotide polymorphisms with hepatocellular carcinoma susceptibility and clinicopathologic development.
Chen TP; Lee HL; Huang YH; Hsieh MJ; Chiang WL; Kuo WH; Chou MC; Yang SF; Yeh CB
Tumour Biol; 2016 Feb; 37(2):2067-74. PubMed ID: 26341495
[TBL] [Abstract][Full Text] [Related]
28. Association of PINX1 but not TEP1 Polymorphisms with Progression to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B Virus Infection.
Sriprapun M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Tangkijvanich P
Asian Pac J Cancer Prev; 2016; 17(4):2019-25. PubMed ID: 27221889
[TBL] [Abstract][Full Text] [Related]
29. ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma.
Zhu G; Liao X; Han C; Liu X; Yu L; Qin W; Lu S; Su H; Chen Z; Liu Z; Liang Y; Huang J; Yu T; Yang C; Huang K; Shang L; Ye X; Li L; Qin X; Xiao K; Peng M; Peng T
Oncol Rep; 2017 Sep; 38(3):1451-1463. PubMed ID: 28714006
[TBL] [Abstract][Full Text] [Related]
30. UBE2L3, a susceptibility gene that plays oncogenic role in hepatitis B-related hepatocellular carcinoma.
Liu Y; Song C; Ni H; Jiao W; Gan W; Dong X; Liu J; Zhu L; Zhai X; Hu Z; Li J
J Viral Hepat; 2018 Nov; 25(11):1363-1371. PubMed ID: 29969176
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis B.
Jung SW; Park NH; Shin JW; Park BR; Kim CJ; Lee JE; Shin ES; Kim JA; Chung YH
Hepatology; 2014 May; 59(5):1912-20. PubMed ID: 23907815
[TBL] [Abstract][Full Text] [Related]
32. A functional polymorphism in PER3 gene is associated with prognosis in hepatocellular carcinoma.
Zhao B; Lu J; Yin J; Liu H; Guo X; Yang Y; Ge N; Zhu Y; Zhang H; Xing J
Liver Int; 2012 Oct; 32(9):1451-9. PubMed ID: 22809120
[TBL] [Abstract][Full Text] [Related]
33. MDR1 gene polymorphism correlated with pathological characteristics and prognosis in patients with primary hepatocellular carcinoma receiving interventional therapy.
Hu W; Huang S; Dong L; Yu C; Li C; Zhang J
Anticancer Drugs; 2019 Mar; 30(3):233-240. PubMed ID: 30779721
[TBL] [Abstract][Full Text] [Related]
34. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
[TBL] [Abstract][Full Text] [Related]
35. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
[TBL] [Abstract][Full Text] [Related]
36. Expression quantitative trait loci for PAX8 contributes to the prognosis of hepatocellular carcinoma.
Ma S; Yang J; Song C; Ge Z; Zhou J; Zhang G; Hu Z
PLoS One; 2017; 12(3):e0173700. PubMed ID: 28339471
[TBL] [Abstract][Full Text] [Related]
37. Donor one‑carbon metabolism gene single nucleotide polymorphisms predict the susceptibility of cancer recurrence after liver transplantation.
Wang C; Lu D; Ling Q; Chen J; Liu Z; Guo H; Xu X; Zheng S
Gene; 2019 Mar; 689():97-101. PubMed ID: 30529095
[TBL] [Abstract][Full Text] [Related]
38. Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.
Shi G; Wang C; Zhang P; Ji L; Xu S; Tan X; Li H
Arch Med Res; 2017 Aug; 48(6):553-560. PubMed ID: 29221801
[TBL] [Abstract][Full Text] [Related]
39. Genetic variants in cell death pathway genes and HBV-related hepatocellular carcinoma among a Chinese Han population.
Liu F; Li F; Luo L; Yang H; Wei Y; Wang W; Yan L; Wen T; Yang J; Li B
Apoptosis; 2017 Aug; 22(8):1035-1047. PubMed ID: 28643196
[TBL] [Abstract][Full Text] [Related]
40. Genetic variants in glucose-6-phosphate isomerase gene as prognosis predictors in hepatocellular carcinoma.
Lyu Z; Chen Y; Guo X; Zhou F; Yan Z; Xing J; An J; Zhang H
Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):698-704. PubMed ID: 27288297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
